Interestingly, in ATLL, CADM1 along with the activated IKK complex promotes NF-κB activation, which, in turn, promotes the proliferation of malignant cells (Sarkar et al., 2019). This evidence concerns the gene NFKB1 and adult T-cell leukemia/lymphoma.